Arteris (NASDAQ:AIP) Issues Quarterly Earnings Results

Arteris (NASDAQ:AIP) posted its earnings results on Tuesday. The company reported ($0.19) EPS for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.08), Zacks reports. Arteris had a negative return on equity of 437.95% and a negative net margin of 65.72%. Arteris updated its FY 2025 guidance to EPS and its Q1 2025 guidance to EPS.

Arteris Stock Performance

Shares of NASDAQ:AIP traded up $0.38 during trading on Tuesday, hitting $10.14. The company’s stock had a trading volume of 340,789 shares, compared to its average volume of 317,106. The company has a 50-day moving average of $10.54 and a 200-day moving average of $8.67. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. The firm has a market cap of $407.43 million, a price-to-earnings ratio of -10.56 and a beta of 1.18. Arteris has a 12 month low of $5.76 and a 12 month high of $12.64.

Insider Activity at Arteris

In related news, Director Isabelle F. Geday sold 15,550 shares of the stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $9.03, for a total value of $140,416.50. Following the completion of the sale, the director now directly owns 121,213 shares of the company’s stock, valued at approximately $1,094,553.39. This represents a 11.37 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Nicholas B. Hawkins sold 5,000 shares of Arteris stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $8.56, for a total transaction of $42,800.00. Following the transaction, the chief financial officer now directly owns 190,414 shares in the company, valued at $1,629,943.84. This represents a 2.56 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 367,157 shares of company stock worth $3,828,388. 33.70% of the stock is owned by company insiders.

Analysts Set New Price Targets

Separately, Rosenblatt Securities restated a “buy” rating and set a $15.00 target price on shares of Arteris in a research note on Tuesday.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.